Key result
Intraventricular nicardipine increases cerebral blood flow and oxygenation in a case of refractory cerebral vasospasm.
Why the study?
Therapeutic options for patients with treatment-refractory cerebral vasospasm after aneurysmal subarachnoid hemorrhage are limited, especially with significant cardiopulmonary disease.
Does intraventricular nicardipine improve neurophysiology in patients with treatment-refractory vasospasm after aneurysmal subarachnoid hemorrhage?
Case Report (n=1)
Does intraventricular nicardipine improve neurophysiology in patients with treatment-refractory vasospasm after aneurysmal subarachnoid hemorrhage?
Intraventricular nicardipine may serve as an effective rescue therapy to improve cerebral blood flow and oxygenation in patients with refractory cerebral vasospasm.
Should not change practice in refractory vasospasm; hypothesis-generating for intraventricular nicardipine.
BACKGROUND: Cerebral vasospasm after aneurysmal subarachnoid hemorrhage can lead to considerable mortality and morbidity affecting the intracranial vessels, leading to delayed cerebral ischemia and stroke. Therapeutic options for patients with treatment-refractory vasospasm are limited, particularly in the setting of significant cardiopulmonary disease. Administration of nicardipine, a calcium channel blocker, into the intrathecal space may represent a potential treatment option for this population. OBSERVATIONS: A 56-year-old woman had treatment-refractory vasospasm, severe acute respiratory distress syndrome, and Takotsubo cardiomyopathy. As an adjunct to vasopressor administration and endovascular intraarterial calcium channel blocker administration, the patient received intraventricular nicardipine. The patient demonstrated improved neurophysiology on invasive multimodality neuromonitoring, with increased cerebral blood flow and oxygenation as a result of intraventricular nicardipine administration. LESSONS: Intraventricular nicardipine can be used as rescue therapy for patients with treatment-refractory cerebral vasospasm. This case demonstrates that intrathecal nicardipine may prevent delayed ischemic neurological deficits and improve outcomes.
No takes yet. Share an insight, caveat, or question.
Grandhi et al. (2022) conducted a case report in treatment-refractory vasospasm in aneurysmal subarachnoid hemorrhage (n=1). Intraventricular nicardipine was evaluated on neurophysiology on invasive multimodality neuromonitoring. Intraventricular nicardipine administration in a patient with treatment-refractory cerebral vasospasm improved neurophysiology, increasing cerebral blood flow and oxygenation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: